Login/Sign Up

MRP ₹58900
(Inclusive of all Taxes)
₹8835.0 Cashback (15%)
Hemlibra 30 mg Injection is a Monoclonal antibody used to prevent or reduce bleeding episodes in individuals with haemophilia A, a condition caused by a missing or defective blood clotting factor. Hemlibra 30 mg Injection connects activated factor IX and factor X, promoting effective clot formation in individuals with haemophilia A. This process helps prevent and minimize bleeding episodes, including in patients with factor VIII inhibitors. The common side effects may include redness, tenderness, warmth, or itching at the injection site, joint pain and headache.
Provide Delivery Location
About Hemlibra 30 mg Injection
Hemlibra 30 mg Injection is used to prevent or reduce bleeding episodes in individuals with haemophilia A. Haemophilia A is a genetic bleeding disorder caused by a deficiency or absence of clotting factor VIII that impairs blood clotting ability. It leads to prolonged bleeding episodes, often following injuries or surgeries, and can cause spontaneous internal bleeding.
Hemlibra 30 mg Injection contains Emicizumab, which works by replicating the function of factor VIII, a crucial protein for blood clotting. It connects activated factor IX and factor X, promoting effective clot formation in individuals with haemophilia A. This process helps prevent and minimize bleeding episodes, including in patients with factor VIII inhibitors.
The dose and duration of treatment with Hemlibra 30 mg Injection may vary depending on your medical condition. The common side effects of Hemlibra 30 mg Injection include redness, tenderness, warmth, or itching at the injection site, as well as joint pain and headache. Most of these side effects resolve gradually over time. However, consult the doctor if any of these persist or worsen.
Inform your doctor if you are pregnant or planning pregnancy or breastfeeding before treatment with Hemlibra 30 mg Injection. Hemlibra 30 mg Injection is safe for children if prescribed by the doctor. Avoid alcohol consumption while taking Hemlibra 30 mg Injection to prevent unpleasant side effects. Hemlibra 30 mg Injection may cause dizziness; therefore, avoid driving or operating heavy machinery unless fully alert. Inform your doctor about all the medicines you are taking and about your pre-existing health conditions.
Uses of Hemlibra 30 mg Injection
Hemlibra 30 mg Injection is used to prevent or reduce bleeding episodes in individuals with haemophilia A (a genetic bleeding disorder). The detailed uses of Hemlibra 30 mg Injection are as follows:

Have a query?
Directions for Use
Medicinal Benefits
Hemlibra 30 mg Injection contains Emicizumab, which belongs to a group of medications called Monoclonal antibodies. It is used to prevent or reduce bleeding episodes in individuals with haemophilia A (a genetic bleeding disorder). Hemlibra 30 mg Injection replicates the function of factor VIII, a crucial protein for blood clotting. It connects activated factor IX and factor X, promoting effective clot formation in individuals with haemophilia A. This process helps prevent and minimize bleeding episodes, including in patients with factor VIII inhibitors.
How Hemlibra 30 mg Injection Works
Storage
What if I have taken an overdose of Hemlibra 30 mg Injection
Drug Warnings
Inform your doctor if you are using factor VIII or a bypassing agent, as these may increase the risk of blood clots, particularly when combined with activated prothrombin complex concentrate (aPCC). You may need to stop using bypassing agents or adjust their dosage as instructed by your doctor. Also, inform your doctor about any pre-existing medical conditions and all medications you are taking, including over-the-counter drugs, vitamins, and herbal supplements. Let your doctor know if you are pregnant or planning to become pregnant.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
Alcohol
Consult your doctor
The interaction of alcohol with Hemlibra 30 mg Injection is unknown. If you have any concerns, please discuss them with your doctor.
Pregnancy
Caution
Please inform your doctor if you are pregnant or planning to become pregnant; your doctor will administer Hemlibra 30 mg Injection only if the benefits outweigh the risks. Also, women who are capable of becoming pregnant must use effective contraception during and for a minimum of 6 months after stopping treatment with Hemlibra 30 mg Injection.
Breast Feeding
Consult your doctor
It is unknown if Hemlibra 30 mg Injection passes into breast milk. Therefore, please inform your doctor if you are breastfeeding. Your doctor decides based on the benefits and risks of Hemlibra 30 mg Injection to the mother and baby.
Driving
Safe if prescribed
Hemlibra 30 mg Injection usually does not affect your ability to drive or operate machines.
Liver
Consult your doctor
Please inform your doctor if you have liver impairment/liver disease before receiving Hemlibra 30 mg Injection.
Kidney
Consult your doctor
Please inform your doctor if you have kidney impairment/kidney disease before receiving Hemlibra 30 mg Injection.
Children
Safe if prescribed
Hemlibra 30 mg Injection is safe for children if prescribed by a doctor. The dose and duration may vary depending on the child’s weight and the severity of the child's medical condition.
Heart
Please inform your doctor if you have heart problems before receiving Hemlibra 30 mg Injection, as there is limited information available on its safety in such cases.
Geriatrics
Safe if prescribed
Hemlibra 30 mg Injection is generally safe for geriatric individuals. Please consult your doctor if you have any concerns.
Hemlibra 30 mg Injection belongs to the group of medications called Monoclonal antibodies used to prevent or reduce bleeding episodes in individuals with haemophilia A, a genetic bleeding disorder caused by a clotting factor VIII deficiency.
Hemlibra 30 mg Injection contains Emicizumab. It replicates the function of factor VIII, a crucial protein for blood clotting. It connects activated factor IX and factor X, promoting effective clot formation in individuals with hemophilia A. This process helps prevent and minimize bleeding episodes, including in patients with factor VIII inhibitors.
If you use Hemlibra 30 mg Injection with a bypassing agent and if you experience confusion, weakness, vomiting, stomach or back pain, less urination, chest pain, trouble breathing, coughing blood, fast heartbeat, swelling or redness in your arms or legs, eye pain, or vision issues, contact your doctor immediately.
Hemlibra 30 mg Injection may cause common side effects like redness, tenderness, warmth, or itching at the injection site, joint pain, and headache. However, please consult your doctor if any of these side effects persist or worsen.
Country of origin
Manufacturer/Marketer address
Buy best Cardiology products by
Torrent Pharmaceuticals Ltd
Sun Pharmaceutical Industries Ltd
Lupin Ltd
Intas Pharmaceuticals Ltd
Cipla Ltd
Micro Labs Ltd
Macleods Pharmaceuticals Ltd
Abbott India Ltd
Ajanta Pharma Ltd
Ipca Laboratories Ltd
Eris Life Sciences Ltd
Mankind Pharma Pvt Ltd
Lloyd Healthcare Pvt Ltd
Dr Reddy's Laboratories Ltd
Emcure Pharmaceuticals Ltd
Alembic Pharmaceuticals Ltd
Glenmark Pharmaceuticals Ltd
Alkem Laboratories Ltd
Zydus Healthcare Ltd
East West Pharma India Pvt Ltd
USV Pvt Ltd
Aristo Pharmaceuticals Pvt Ltd
Alteus Biogenics Pvt Ltd
J B Chemicals & Pharmaceuticals Ltd
Elbrit Life Sciences Pvt Ltd
Fusion Health Care Pvt Ltd
Eswar Therapeutics Pvt Ltd
La Renon Healthcare Pvt Ltd
Zydus Cadila
Akumentis Healthcare Ltd
Hbc Life Sciences Pvt Ltd
Troikaa Pharmaceuticals Ltd
Knoll Healthcare Pvt Ltd
Corona Remedies Pvt Ltd
Morepen Laboratories Ltd
Shrrishti Health Care Products Pvt Ltd
Prevego Healthcare & Research Pvt Ltd
Lividus Pharmaceuticals Pvt Ltd
Medley Pharmaceuticals Ltd
Cadila Pharmaceuticals Ltd
Jubilant Lifesciences Ltd
Msn Laboratories Pvt Ltd
Zuventus Healthcare Ltd
Steris Healthcare
Ranmarc Labs
Elder Pharmaceuticals Ltd
Tas Med India Pvt Ltd
Unison Pharmaceuticals Pvt Ltd
Primus Remedies Pvt Ltd
Leeford Healthcare Ltd
Blue Cross Laboratories Pvt Ltd
Azkka Pharmaceuticals Pvt Ltd
Sanofi India Ltd
Sinsan Pharmaceuticals Pvt Ltd
Nirvana India Pvt Ltd
Knoll Pharmaceuticals Ltd
Orsim Pharma
Systopic Laboratories Pvt Ltd
Indiabulls Pharmaceuticals Pvt Ltd
RPG Life Sciences Ltd
Biochem Pharmaceutical Industries Ltd
Johnlee Pharmaceuticals Pvt Ltd
Olcare Laboratories Pvt Ltd
Vasu Organics Pvt Ltd
Cadila Healthcare Ltd
Econ Healthcare
Shine Pharmaceuticals Ltd
Xemex Life Sciences
Elicad Pharmaceuticals Pvt Ltd
Elinor Pharmaceuticals (P) Ltd
Sunij Pharma Pvt Ltd
Orris Pharmaceuticals
Atos Lifesciences Pvt Ltd
FDC Ltd
Lia Life Sciences Pvt Ltd
Pfizer Ltd
MEDICAMEN BIOTECH LTD
Nicholas Piramal India Ltd
Astra Zeneca Pharma India Ltd
Lakshya Life Sciences Pvt Ltd
Opsis Care Lifesciences Pvt Ltd
Alvio Pharmaceuticals Pvt Ltd
Biocon Ltd
Finecure Pharmaceuticals Ltd
Glynis Pharmaceuticals Pvt Ltd
Indoco Remedies Ltd
Med Manor Organics Pvt Ltd
Acmedix Pharma Llp
Allysia Lifesciences Pvt Ltd
Chemo Healthcare Pvt Ltd
Pficus De Med Pvt Ltd
Proqol Health Care Pvt Ltd
Divine Savior Pvt Ltd
Enovus Healthcare Pvt Ltd
Ergos Life Sciences Pvt Ltd
Samarth Life Sciences Pvt Ltd
Signova Pharma
ALICAN PHARMACEUTICAL PVT LTD
Auspharma Pvt Ltd
Maxford Labs Pvt Ltd